Archives of Plastic Surgery

Korean Society of Plastic and Reconstructive Surgeons (대한성형외과학회)
권호 표지
DOI QR코드

DOI QR Code

Distribution of Basal Cell Carcinoma and Squamous Cell Carcinoma by Facial Esthetic Unit

  • Choi, Jung Hun (Department of Plastic and Reconstructive Surgery, Sanggye Paik Hospital, Inje University College of Medicine) ;
  • Kim, Young Joon (Department of Plastic and Reconstructive Surgery, Sanggye Paik Hospital, Inje University College of Medicine) ;
  • Kim, Hoon (Department of Plastic and Reconstructive Surgery, Sanggye Paik Hospital, Inje University College of Medicine) ;
  • Nam, Sang Hyun (Department of Plastic and Reconstructive Surgery, Sanggye Paik Hospital, Inje University College of Medicine) ;
  • Choi, Young Woong (Department of Plastic and Reconstructive Surgery, Sanggye Paik Hospital, Inje University College of Medicine)
  • Received : 2013.03.25
  • Accepted : 2013.05.21
  • Published : 2013.07.15
Download PDF
⟨ Previous Next ⟩

Abstract

Background The most common cutaneous malignant masses are basal cell carcinoma (BCC) and squamous cell carcinoma. The predominant site of a malignant mass is the face, which has many opportunities to be exposed to ultraviolet radiation. However the predilection sites of malignant masses have been equivocal due to the use of general regions, rather than anatomical landmarks, in surveys. A facial esthetic unit is an anatomical site classified as an area of similar facial contour characteristics that can be distinguished from other areas. The purpose of this study is to determine widely accepted anatomical landmarks using the esthetic unit. Methods We retrospectively analyzed 118 cases of malignant masses in our clinic from January 2005 to October 2012. We evaluated the patients' age, gender, and predilection site of the malignant mass by esthetic unit through pathology, medical records and patient photographs. We mapped the occurrence site of the malignant mass on schematic drawings of the esthetic units. Results Most of the malignant masses were BCC. The ratio of males to females was 1:1.41. The frequent predilection site of a malignant mass was on the nasal unit (33.1%), followed by the buccal unit (11.0%). Primary closure was the most common method of repairing a surgical defect (38.9%), followed by a local flap (35.5%). Conclusions This review described the relationship between clinical characteristics and esthetic units by proposing objective predilection sites for malignant masses, which can be used commonly as a framework in the study of malignant masses by unifying equivocal occurrence sites.

Keywords

References

  1. Glanz K, Schoenfeld ER, Steffen A. A randomized trial of tailored skin cancer prevention messages for adults: Project SCAPE. Am J Public Health 2010;100:735-41. https://doi.org/10.2105/AJPH.2008.155705
  2. Hwang JI, Kim HS, Park H, et al. A statistical survey of major cutaneous malignant tumors for the last 10 years (2000-2010, North-east Gyeonggido Province). Korean J Dermatol 2011;49:97-105.
  3. Jung YH, Kim SS. A clinical study in malignant skin tumors. J Korean Soc Plast Reconstr Surg 1982;9:377-88.
  4. Hong H, Ji JH, Choi EH. A clinical observation of cutaneous malignant tumors and premalignant lesions in gangwon province over 10 years (1999-2008). Korean J Dermatol 2012;50:95-100.
  5. Shin JH, Cho S, Whang KK, et al. An epidemiologic analysis of cutaneous malignant tumors over 15 years (1984-1998). Korean J Dermatol 1999;37:1743-51.
  6. Mora RG, Robins P. Basal-cell carcinomas in the center of the face: special diagnostic, prognostic, and therapeutic considerations. J Dermatol Surg Oncol 1978;4:315-21. https://doi.org/10.1111/j.1524-4725.1978.tb00435.x
  7. Kim JW, Oh CH, Kim IH. Distribution of histologic subtypes of basal cell carcinoma by facial aesthetic unit and subunit. Korean J Dermatol 2000;38:31-7.
  8. Kim HR, Na CH, Shin BS, et al. A statistical study of cutaneous basal cell carcinoma and squamous cell carcinoma in Gwangju City and Chonnam Province (2006-2010). Korean J Dermatol 2011;49:1073-8.
  9. Kim YP, Chun IK, Lee HH. A 10 year period (1968-1977) of clinical observation of cutaneous malignant tumors. Korean J Dermatol 1978;16:19-29.
  10. Gonzalez-Ulloa M. Restoration of the face covering by means of selected skin in regional aesthetic units. Br J Plast Surg 1956;9:212-21. https://doi.org/10.1016/S0007-1226(56)80036-2
  11. Armstrong BK, Kricker A. Skin cancer. Dermatol Clin 1995;13:583-94.
  12. Gloster HM Jr, Brodland DG. The epidemiology of skin cancer. Dermatol Surg 1996;22:217-26.
  13. Giles GG, Marks R, Foley P. Incidence of non-melanocytic skin cancer treated in Australia. Br Med J (Clin Res Ed) 1988;296:13-7. https://doi.org/10.1136/bmj.296.6614.13
  14. Vana J. Epidemiology. In: Helm F, editor. Cancer dermatology. 1st ed. Philadelphia: Lea & Febiger; 1979. p.3-15.
  15. Lee YJ, Seo SJ, Kim MN, et al. A 10 year period (1984-1993) of clinical observation of cutaneous malignant tumors. Korean J Dermatol 1995;33:679-85.
  16. Seo JJ, Won YH, Kim SJ, et al. A clinical observation of cutaneous malignant tumors over 10 years (1987-1996, Chonnam Province ). Korean J Dermatol 1998;36:812-9.
  17. Yoon TJ, Kim HS, Oh CW, et al. A clinical investigation of cutaneous malignant tumors in western Gyeongnam Province. Korean J Dermatol 1997;35:956-62.
  18. Jeong KB, Kim HC, Shin DH, et al. A clinical observation of cutaneous premalignant and malignant tumors. Korean J Dermatol 2002;40:924-31.
  19. Cho KH, Lee YS. A clinical observation of cutaneous malignant tumors. Korean J Dermatol 1984;22:394-403.
  20. Narayanan DL, Saladi RN, Fox JL. Ultraviolet radiation and skin cancer. Int J Dermatol 2010;49:978-86. https://doi.org/10.1111/j.1365-4632.2010.04474.x
  21. Randle HW. Basal cell carcinoma. Identification and treatment of the high-risk patient. Dermatol Surg 1996;22:255-61.
  22. Bart RS, Schrager D, Kopf AW, et al. Scalpel excision of basal cell carcinomas. Arch Dermatol 1978;114:739-42. https://doi.org/10.1001/archderm.1978.01640170039007
  23. Buettner PG, Raasch BA. Incidence rates of skin cancer in Townsville, Australia. Int J Cancer 1998;78:587-93. https://doi.org/10.1002/(SICI)1097-0215(19981123)78:5<587::AID-IJC10>3.0.CO;2-E

Cited by

  1. Non-Melanocytic Benign Tumors of the Face: A Retrospective Study vol.42, pp.2, 2013, https://doi.org/10.5999/aps.2015.42.2.201
  2. Surgical Pearl on Reconstructing Surgical Defects of the Nasal Tip vol.8, pp.1, 2013, https://doi.org/10.4081/dr.2016.6828
  3. A Retrospective Clinical View of Basal Cell Carcinoma and Squamous Cell Carcinoma in the Head and Neck Region: A Single Institution's Experience of 247 Cases over 19 Years vol.17, pp.2, 2013, https://doi.org/10.7181/acfs.2016.17.2.56
  4. Evidence-Based Medicine: Cutaneous Facial Malignancies: Nonmelanoma Skin Cancer vol.139, pp.1, 2013, https://doi.org/10.1097/prs.0000000000002853
  5. Concordant Surgical Treatment: Non-melanocytic Skin Cancer of the Head and Neck vol.18, pp.1, 2013, https://doi.org/10.7181/acfs.2017.18.1.37
  6. High-Risk BCC Of the Lower Eyelid in Patient with Presternal Located Cutaneous Melanoma and BCC Of the Shoulder: Melolabial Advancement Flap Combined with Undermining Surgical Approach As Promising Co vol.6, pp.11, 2013, https://doi.org/10.3889/oamjms.2018.408
  7. Perialar Semilunar Advancement Flap for the Reconstruction of Nasal Sidewall Defects: Our Experience vol.12, pp.1, 2019, https://doi.org/10.4103/jcas.jcas_156_18
  8. Nonmelanoma Facial Skin Cancer: A Review of Diagnostic Strategies, Surgical Treatment, and Reconstructive Techniques vol.12, pp.None, 2013, https://doi.org/10.1177/1179550619865278
  9. Single center evidence for the treatment of basal cell carcinoma of the head and neck vol.90, pp.1, 2019, https://doi.org/10.23750/abm.v90i1.6395
  10. Kombination unterschiedlicher Versorgungsmöglichkeiten zur Defektdeckung im exponierten Gesichtsbereich vol.12, pp.3, 2013, https://doi.org/10.1007/s12631-019-0189-0
  11. Anatomic study of the arterial territories of the face depending on the external carotid artery branches vol.104, pp.344, 2013, https://doi.org/10.1016/j.morpho.2019.08.002
  12. Key characteristics of basal cell carcinoma with large subclinical extension vol.34, pp.3, 2020, https://doi.org/10.1111/jdv.15884
  13. Imiquimod for Superficial Basal Cell Carcinomas vol.60, pp.2, 2013, https://doi.org/10.1097/iio.0000000000000299
  14. Real‐life data on basal cell carcinoma treatment: Insights on clinicians' therapeutic choices from an institutional hospital registry vol.33, pp.6, 2013, https://doi.org/10.1111/dth.14414
  15. Treatment of Non-melanoma Skin Cancers in the Absence of Mohs Micrographic Surgery vol.8, pp.12, 2013, https://doi.org/10.1097/gox.0000000000003300
  16. Exploring the Facial Color Representative Regions Using the Humanae Images vol.2021, pp.14, 2013, https://doi.org/10.2352/j.imagingsci.technol.2020.64.6.060406
  17. Three‐dimensional histology vs. serial section histology in the treatment of primary basal cell carcinoma: a randomized, prospective, blinded study of 569 tumours vol.35, pp.6, 2013, https://doi.org/10.1111/jdv.17155
  18. The anatomical distribution of non‐melanoma skin cancer: a retrospective cohort study of 22 303 Australian cases vol.91, pp.12, 2013, https://doi.org/10.1111/ans.17030
  19. Combining Nd:YAG laser with optical coherence tomography for nonsurgical treatment of basal cell carcinoma vol.54, pp.1, 2013, https://doi.org/10.1002/lsm.23455